Annualized cost comparisons in 2026: Bariatric surgery (gastric sleeve or bypass): ,000 to ,000 one-time, often covered by insurance for severe obesity Wegovy at list price: about ,200 per year Zepbound at list price: about ,720 per year Compounded semaglutide (legitimate US pharmacy): ,800 to ,000 per year Compounded tirzepatide: ,000 to ,000 per year Retatrutide at launch will likely fit in the Wegovy/Zepbound range at list price, with significantly lower out-of-pocket cost for insured patients with savings card eligibility
Approved indication: Reduction of excess abdominal fat in HIV-infected patients with lipodystrophy
Addressing these related concerns can indirectly but meaningfully improve weight loss results
In America, most of us have compromised gut function due to poor diet, stress, alcohol, and certain medications, and therefore could benefit from IV nutrition